Otsuka invests $88M into digital meds deal with Proteus; Celgene amps up research pact with Evotec
→ Japan’s Otsuka has handed over an $88 million payment to Proteus Digital Health for a collaboration on the development of digital meds. They …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
